Are you Dr. Childs?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 91 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
10 Center Dr
Bldg 10, Crc Room 3e-5330
Bethesda, MD 20892Phone+1 301-594-8008Fax+1 301-480-2664
Summary
- Dr. Richard Childs, MD is a hematologist in Bethesda, Maryland. He is currently licensed to practice medicine in Maryland and Florida. He is a Senior Investigator,Laboratory of Transplantation Immunotherapy Rear Admiral (RADM) at Lung.
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1995 - 1998
- University of FloridaResidency, Internal Medicine, 1991 - 1995
- Georgetown University School of MedicineClass of 1991
Certifications & Licensure
- MD State Medical License 1995 - 2020
- FL State Medical License 1992 - 2000
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Elected Member The American Society for Clinical Investigation, 2009
Clinical Trials
- Stem Cell Transplantation for Metastatic Solid Tumors Start of enrollment: 1999 Mar 12
- Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Melanoma Start of enrollment: 1999 Jan 01
- Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer Start of enrollment: 1998 Feb 09
- Join now to see all
Publications & Presentations
PubMed
- 26 citationsEndogenous Retroviruses as Targets for Antitumor Immunity in Renal Cell Cancer and Other TumorsElena Cherkasova, Quinn Weisman, Richard W. Childs
Frontiers in Oncology. 2013-09-17 - 66 citationsOutbreak of Human Parainfluenza Virus 3 Infections in a Hematopoietic Stem Cell Transplant PopulationKaroll J. Cortez, Dean D. Erdman, Teresa C. T. Peret, Vee J. Gill, Richard W. Childs
The Journal of Infectious Diseases. 2001-11-01 - 72 citationsImatinib synergizes with donor lymphocyte infusions to achieve rapid molecular remission of CML relapsing after allogeneic stem cell transplantation.Bipin N. Savani, Aldemar Montero, Roger Kurlander, Richard W. Childs, Nancy F. Hensel
Bone Marrow Transplantation. 2005-12-01
Press Mentions
- Blood Test May Identify Patients with AML at Greater Risk of Relapse After Bone Marrow TransplantMarch 9th, 2023
- After 2-Year, 'Nerve-Wracking' Bone Marrow Treatment, Crystal Lake Girl Returns to SchoolSeptember 19th, 2017
Grant Support
- Cyclosporine Inhalation Solution (CIS) Treatment Of Bronchiolitis ObliteransNational Heart, Lung, And Blood Institute2010–2011
- Allogeneic Immunotherapy For Cancer And Nonmalignant Hematological DisordersNational Heart, Lung, And Blood Institute2009–2011
- Allogeneic Immunotherapy For Cancer And Nonmalignant Hematological DisordersNational Heart, Lung, And Blood Institute2007–2008
- Allogeneic Immunotherapy For Cancer And Nonmalignant HEMNational Heart, Lung, And Blood Institute2006
- Allogeneic ImmunotherapyNational Heart, Lung, And Blood Institute2000–2005
Professional Memberships
- Member